Results 21 to 30 of about 68,822 (295)

Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial.

open access: yesJAMA Surgery, 2020
Importance Because inadvertent damage of parathyroid glands can lead to postoperative hypocalcemia, their identification and preservation, which can be challenging, are pivotal during total thyroidectomy.
F. Benmiloud   +10 more
semanticscholar   +1 more source

Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response

open access: yesEndocrine, 2021
Hypocalcemia has been identified as a major distinctive feature of COVID-19, predicting poor clinical outcomes. Among the mechanisms underlying this biochemical finding, high prevalence of vitamin D (VD) deficiency in COVID-19 patients reported so far in
L. di Filippo   +6 more
semanticscholar   +1 more source

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

open access: yesEndocrine, 2020
Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2), presents primarily with fever, dry cough, and fatigue or myalgia [1].
L. di Filippo   +7 more
semanticscholar   +1 more source

Pseudohypoparathyroidism: A Rare Cause of Status Epilepticus

open access: yesApollo Medicine, 2022
Hypocalcemia can result in a variety of symptoms which include paresthesias, muscle spasms, cramps, tetany and circumoral numbness. Arrhythmias, heart failure and seizures constitute the serious symptoms arising from hypocalcemia. Seizures resulting from
Vinit Suri   +3 more
doaj   +1 more source

European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
Some 5861 patients undergoing first‐time surgery for sporadic primary hyperparathyroidism were registered in the Eurocrine® database between 2015 and 2018. The use of intraoperative parathyroid hormone measurement decreased the risk of conversion and persistent hypercalcaemia.
A. Bergenfelz   +3 more
wiley   +1 more source

High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study

open access: yesFrontiers in Medicine, 2021
Purpose: To compare serum total calcium and phosphate levels in patients with non-severe COVID-19 with age, sex, and serum 25-hydroxyvitamin D level matched healthy adult cohort.
R. Pal   +10 more
semanticscholar   +1 more source

Preoperative vitamin D level as a post-total thyroidectomy hypocalcemia predictor: a prospective study

open access: yesBrazilian Journal of Otorhinolaryngology, 2021
Introduction: Hypocalcemia is one of the most common complications after total thyroidectomy. Preoperative serum vitamin D concentration has been postulated as a risk factor for this complication.
Carlos Segundo Paiva Soares   +2 more
doaj   +1 more source

Massive transfusions and severe hypocalcemia: An opportunity for monitoring and supplementation guidelines

open access: yesTransfusion, 2021
Massive transfusion protocols (MTPs) are associated with severe hypocalcemia, contributing to coagulopathy and mortality in severely injured patients. Severity of hypocalcemia following massive transfusion activation and appropriate treatment strategies ...
Chad Hall   +7 more
semanticscholar   +1 more source

Use of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial.

open access: yesJAMA Otolaryngology - Head and Neck Surgery, 2021
Importance Total thyroidectomy is associated with risks related to temporary hypocalcemia and vocal quality dysfunction. Dexamethasone has been proposed to have a physiological effect on hypocalcemia and voice quality. Objective To assess the effect of
A. Dhahri   +6 more
semanticscholar   +1 more source

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases. [PDF]

open access: yes, 2019
Denosumab has been used successfully to treat disease-associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central ...
Bernthal, Nicholas M   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy